2017缓和医疗(安宁疗护)国际高峰论坛暨艺术行动在京召开

2017-10-18 张思玮 科学网

10月14日,由北京生前预嘱推广协会、解放军总医院和中国老年医学学会联合举办的“2017缓和医疗(安宁疗护)国际高峰论坛暨艺术行动”在北京召开。

10月14日,由北京生前预嘱推广协会、解放军总医院和中国老年医学学会联合举办的“2017缓和医疗(安宁疗护)国际高峰论坛暨艺术行动”在北京召开。全国政协副主席韩启德、原卫生部副部长黄洁夫及国家卫计委相关领导现场致辞。来自世界各地,包括美国、英国以及中国大陆和香港的700多位医疗专家等相关人士出席了此次大会。

缓和医疗(Palliative Care)在我国又称“安宁疗护”“姑息治疗”“舒缓医疗”,根据世界卫生组织(WHO)的定义,缓和医疗是一种帮助患者及其亲属更好应对威胁生命疾病的方法,通过对疼痛以及其它躯体、心理、灵性等问题的早期发现、准确评估和有效防治以减轻痛苦,并改善患者及亲属的生活质量。

缓和医疗并不是临终关怀,它作为一门综合性临床医学,需要跨学科的团队对患者及亲属提供疗护。与临终关怀(Hospice)的主要区别在于医疗方案的实施对象、周期、治疗方法和地点,而临终关怀是缓和医疗的一个重要组成部分。

本次“世界临终关怀与缓和医疗日”的主题是“全民医保与缓和医疗”。来自世界各地的知名缓和医疗专家分别从缓和医疗学科发展的不同视角为与会者带来了精彩的学术演讲。在圆桌论坛中,各界代表对中国缓和医疗发展模式及前景展开了实质性的讨论,从更高角度、更广视野对中国缓和医疗进行了多维度的解析与思考,展望了中国缓和医疗的发展动向和趋势。

专家表示,中国缓和医疗事业正在摸索自己的成长之路。目前,国内相关医疗机构已经设立了缓和医疗病床,并逐步开展临床实践,深入探讨学科走向,相关政策逐步配套。未来,中国特色的缓和医疗势必将构建一套适应自身制度、文化、社会与经济需求的发展模式。

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1662913, encodeId=1f8316629137b, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Wed Mar 07 13:28:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700836, encodeId=952a1e00836bf, content=<a href='/topic/show?id=dfba86e3142' target=_blank style='color:#2F92EE;'>#艺术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86731, encryptionId=dfba86e3142, topicName=艺术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8030252779, createdName=kksonne, createdTime=Sun Mar 18 00:28:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664436, encodeId=1ff81664436b3, content=<a href='/topic/show?id=1433e92044a' target=_blank style='color:#2F92EE;'>#缓和医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79204, encryptionId=1433e92044a, topicName=缓和医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f525763636, createdName=ms3415360956839622, createdTime=Sat Jan 06 22:28:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527245, encodeId=b788152e24552, content=<a href='/topic/show?id=e34a45e7319' target=_blank style='color:#2F92EE;'>#安宁疗护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45773, encryptionId=e34a45e7319, topicName=安宁疗护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c03111824587, createdName=tigerlr102, createdTime=Thu Oct 19 21:28:00 CST 2017, time=2017-10-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1662913, encodeId=1f8316629137b, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Wed Mar 07 13:28:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700836, encodeId=952a1e00836bf, content=<a href='/topic/show?id=dfba86e3142' target=_blank style='color:#2F92EE;'>#艺术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86731, encryptionId=dfba86e3142, topicName=艺术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8030252779, createdName=kksonne, createdTime=Sun Mar 18 00:28:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664436, encodeId=1ff81664436b3, content=<a href='/topic/show?id=1433e92044a' target=_blank style='color:#2F92EE;'>#缓和医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79204, encryptionId=1433e92044a, topicName=缓和医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f525763636, createdName=ms3415360956839622, createdTime=Sat Jan 06 22:28:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527245, encodeId=b788152e24552, content=<a href='/topic/show?id=e34a45e7319' target=_blank style='color:#2F92EE;'>#安宁疗护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45773, encryptionId=e34a45e7319, topicName=安宁疗护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c03111824587, createdName=tigerlr102, createdTime=Thu Oct 19 21:28:00 CST 2017, time=2017-10-19, status=1, ipAttribution=)]
    2018-03-18 kksonne
  3. [GetPortalCommentsPageByObjectIdResponse(id=1662913, encodeId=1f8316629137b, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Wed Mar 07 13:28:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700836, encodeId=952a1e00836bf, content=<a href='/topic/show?id=dfba86e3142' target=_blank style='color:#2F92EE;'>#艺术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86731, encryptionId=dfba86e3142, topicName=艺术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8030252779, createdName=kksonne, createdTime=Sun Mar 18 00:28:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664436, encodeId=1ff81664436b3, content=<a href='/topic/show?id=1433e92044a' target=_blank style='color:#2F92EE;'>#缓和医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79204, encryptionId=1433e92044a, topicName=缓和医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f525763636, createdName=ms3415360956839622, createdTime=Sat Jan 06 22:28:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527245, encodeId=b788152e24552, content=<a href='/topic/show?id=e34a45e7319' target=_blank style='color:#2F92EE;'>#安宁疗护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45773, encryptionId=e34a45e7319, topicName=安宁疗护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c03111824587, createdName=tigerlr102, createdTime=Thu Oct 19 21:28:00 CST 2017, time=2017-10-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1662913, encodeId=1f8316629137b, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Wed Mar 07 13:28:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700836, encodeId=952a1e00836bf, content=<a href='/topic/show?id=dfba86e3142' target=_blank style='color:#2F92EE;'>#艺术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86731, encryptionId=dfba86e3142, topicName=艺术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8030252779, createdName=kksonne, createdTime=Sun Mar 18 00:28:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664436, encodeId=1ff81664436b3, content=<a href='/topic/show?id=1433e92044a' target=_blank style='color:#2F92EE;'>#缓和医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79204, encryptionId=1433e92044a, topicName=缓和医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f525763636, createdName=ms3415360956839622, createdTime=Sat Jan 06 22:28:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527245, encodeId=b788152e24552, content=<a href='/topic/show?id=e34a45e7319' target=_blank style='color:#2F92EE;'>#安宁疗护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45773, encryptionId=e34a45e7319, topicName=安宁疗护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c03111824587, createdName=tigerlr102, createdTime=Thu Oct 19 21:28:00 CST 2017, time=2017-10-19, status=1, ipAttribution=)]